Biofrontera Inc. (BFRI) vs Sonoma Pharmaceuticals, Inc. (SNOA)
- Biofrontera Inc. BFRI 0.82 −3.53%
- Sonoma Pharmaceuticals, Inc. SNOA 1.13 −1.74%
Biofrontera Inc. and Sonoma Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Biofrontera Inc. is the larger, with a market value of $12.6M against $5.5M — 2.3× the size. Sonoma Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 47.0% against 17.8%. Sonoma Pharmaceuticals, Inc. has the higher net margin (−10.3% vs −13.8%) and the lower return on invested capital (−70.0% vs −69.5%). Across the 18 metrics below, Sonoma Pharmaceuticals, Inc. leads on 12 and Biofrontera Inc. on 6.
Valuation
Profitability
| Metric | BFRI | SNOA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 79.25% | 38.91% | 53.94% |
| Operating margin | (14.22%) | (6.41%) | 0.00% |
| Net margin | (13.78%) | (10.33%) | 0.00% |
| Free cash flow margin | (17.17%) | (12.11%) | 0.00% |
| Return on equity | (988.35%) | (42.52%) | (0.40%) |
| Return on assets | (28.80%) | (13.85%) | (3.32%) |
| Return on invested capital | (69.45%) | (69.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack